14 Stocks Jim Cramer Recently Shed Light On
“How did I know to tell you to be ready to buy when the time was right, like I did last night after yesterday's brutal session?... It's all about how to spot a bottom.
Biohaven Ltd. (BHVN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 10,286,937 | $116,139,519 | +84% | 2.38% |
| 2. | D E Shaw D. E. Shaw | 2,694,234 | $30,417,901 | +113% | 0.02% |
| 3. | Citadel Investment Group Ken Griffin | 1,743,993 | $19,689,681 | +75% | 0% |
| 4. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 1,606,777 | $18,140,510 | +3830% | 0.08% |
| 5. | Balyasny Asset Management Dmitry Balyasny | 1,591,054 | $17,963,000 | +318% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.52 | 17,000 | $144,770.30 | 20,000 | 2025-11-17 | Filing | |
| $7.50 | 400,000 | $3,000,000.00 | 2,020,071 | 2025-11-13 | Filing | |
| $7.50 | 3,333,333 | $24,999,997.50 | 5,653,904 | 2025-11-13 | Filing | |
| $7.50 | 333,333 | $2,499,997.50 | 740,546 | 2025-11-13 | Filing | |
| $7.50 | 333,333 | $2,499,997.50 | 1,195,275 | 2025-11-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $41.79 | 11,000 | $459,662.50 | 2,535 | 2023-12-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,939,856 | $112,220,980 | 0.1% | |
| 2. | 9,448,040 | $106,668,371 | 0% | |
| 3. | 6,250,000 | $70,562,500 | 10.44% | |
| 4. | 5,716,487 | $64,539,138 | 0% | |
| 5. | 4,631,317 | $52,287,569 | 1.73% |
News See All
William Blair Maintains Bullish Stance on Biohaven (BHVN), Sees Robust Operational Growth
On November 11, 2025, William Blair kept its “Market Perform” rating. The investment firm sees the FDA’s Complete Response Letter (CRL) for Vyglxia as a key driver for pipeline reprioritization.
10 Best Small-Cap Biotech Stocks to Buy According to Analysts
Small-cap biotech stocks are marking their latest resurgence, attracting renewed investor attention.
Leerink Lowers Biohaven (BHVN) PT to $50 Following Q2 Report, Acknowledging Positive Pipeline Progress
Biohaven Ltd. (NYSE:BHVN) is one of the best small cap stocks with biggest upside potential.
9 Best Small Cap Stocks with Biggest Upside Potential
On August 14, Jonathan Krinsky of BTIG, joined 'Closing Bell' on CNBC to discuss whether the recent rally in small cap stocks is sustainable.
Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders
Biohaven Ltd. (NYSE:BHVN) is one of the Best 52-Week Low Stocks to Buy According to Analysts.. On June 10, Biohaven Ltd.
12 Best 52-Week Low Stocks to Buy According to Analysts
On July 15, the Consumer Price Index data revealed that core inflation increased by 0.2% on the month; however, the annual rate of 2.9% remains within the estimated range.
Biohaven, Bexorg Partner to Accelerate CNS Drug Discovery Using Novel Whole-Brain Platform
Biohaven Ltd. (NYSE:BHVN) is one of the best low priced pharma stocks to buy now.
13 Best Low Priced Pharma Stocks to Buy Now
On July 9, Afsaneh Beschloss, RockCreek Group founder & CEO, joined 'Closing Bell Overtime' on CNBC to talk about the latest round of tariff threats.
Jim Cramer on Biohaven Ltd. (BHVN): “I Think That This is a Buy”
We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at where Biohaven Ltd.
Hedge Fund Resource Center Billionaire Hedge Funds
